Zachary Contreras from Sharp Health Plan discusses findings from the AMCP Nexus study showing that dextromethorphan-bupropion (DM-BUP) was associated with lower total health care costs compared with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results